Big Moving Stock keep track of the biggest moving stocks in the market.


Nasdaq: GOOG NFLX BIIB AMZN IBB TSLA ILMN ALXN WYNN AMGN GMCR SLXP COST FFIV SSYS VRTX SBAC GILD Z
Nyse: ACT V LNKD MCK IVV LMT AGN GS PXD SPG FDX IBM MMM TWC CMI GD HUM NOC APD BDX
New Highs: BLK IBB V SHW MCK IVV ILMN ALXN LMT GS PSA SPG ORLY WHR FDX BCR AMGN MMM GMCR FLT

The Hot Industries

Biotechnology 3
Medical Instruments & Supplies 1
Appliances 1

The Hot Sectors

Financial 5
Healthcare 4
Services 4

CELG Stock Chart


CELG
Analyze

Sector:

Healthcare
Daily

Industry:

Biotechnology
Weekly

Employees:

5,100
Monthly

Website:

http://www.celgene.com

CELG Celgene Corporation

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. The company’s commercial stage products include REVLIMID, an oral immunomodulatory drug for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; VIDAZA, a pyrimidine nucleoside analog to treat intermediate-2 and high-risk MDS, and chronic myelomonocytic leukemia, as well as acute myeloid leukemia (AML); ABRAXANE, a solvent-free chemotherapy product for the treatment of breast, non-small cell lung, pancreatic, and gastric cancers; and POMALYST/IMNOVID for the treatment of multiple myeloma. Its commercial stage products also comprise THALOMID for the patients with multiple myeloma and for the acute treatment of the cutaneous manifestations of erythema nodosum leprosum; ISTODAX to treat cutaneous T-cell lymphoma; and FOCALIN, FOCALIN XR, and RITALIN LA products. The company’s pre clinical and clinical stage products consist of OTEZLA for the treatment of psoriatic arthritis, psoriasis, and ankylosing spondylitis; CC-122 and CC-220 to treat hematological and solid tumor cancers; cellular therapies, such as PDA-001 and PDA-002 for Crohn’s and peripheral arterial diseases; CC-486, to treat MDS, AML, and solid tumors; Sotatercept and ACE-536 for the treatment of anemia in patients with rare blood disorders; CC-223 and CC-115 for lymphomas, hepatocellular, and prostate cancers; and CC-292 for the treatment of chronic lymphocytic leukemia and lymphomas. It has strategic drug discovery collaboration with Abide Therapeutics to enhance the treatment paradigm for patients with immune disorders. Celgene Corporation was founded in 1980 and is headquartered in Summit, New Jersey.

favicon

Stock picks: 14 trades in 73 seconds

31 Oct 2014, 4:29 pmThe "Fast Money" traders share their final trades of the day.
favicon

Jim Cramer's Top Stock Picks: CELG REGN GILD BIIB TTWO CRL FLEX

31 Oct 2014, 4:28 amSearch Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener. NEW YORK (TheStreet) -- Here are some of the hot stocks Jim Cramer talked about on Thursday's Mad Money on CNBC: CELG data by YCharts Celgene , Regeneron , Gilead Sciences and Biogen Idec : Cramer said his "four hoursemen" of biotech continue to march on and remain terrific investments. TTWO ...
favicon

Jim Cramer's 'Mad Money' Recap: Here's Why the Bears Were Dead Wrong

30 Oct 2014, 5:13 pmSearch Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener. NEW YORK ( TheStreet) -- You'll never hear an apology from the bears when they're wrong, Jim Cramer told his Mad Money viewers Thursday as he called out all those who have been predicting doom and gloom as the Federal Reserve ends its bond buying program. Cramer said the critics of the Fed's ...
favicon

Taking Stock

30 Oct 2014, 4:13 pm‘Tis The Season Like a vanishing Halloween ghost, the Federal Reserve ended the tapering of its bond-buying program, at least for the time being. As the Fed announced last month that it intended to end the program this month, the news should not have been surprising although Wall Street seemed shocked and sold off briefly. […] The post Taking Stock appeared first on Laguna Beach Independent ...
favicon

Stock picks: 21 trades in 67 seconds

29 Oct 2014, 5:14 pmWith the end of the Federal Reserve's quantitative easing in sight, the outlook for financial stocks appears bright, Karen Finerman says.
favicon

Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen - Analyst Blog

29 Oct 2014, 12:01 pmBiotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen - Analyst Blog
favicon

Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen

29 Oct 2014, 9:28 amQuite a few biotech companies fared well i the third quarter with earnings surpassing expectations and guidance being raised.
favicon

Celgene: Three cheers for being alive

27 Oct 2014, 10:55 amCelgene: Three cheers for being alive
favicon

Jim Cramer's Top Stock Picks: CELG FTK BA JAH AVT

24 Oct 2014, 4:28 amSearch Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener. NEW YORK (TheStreet) -- Here are some of the hot stocks Jim Cramer talked about on Thursday's Mad Money on CNBC: CELG data by YCharts Celgene : Cramer said this biotech had a lot of positive things to say when itareleased earnings and remains one of his favorites in the group. FTK data by ...
favicon

Celgene beats Street 3Q forecasts

23 Oct 2014, 5:54 amThe Summit, New Jersey-based company said it had profit of 61 cents per share. Earnings, adjusted for one-time gains and costs, were 97 cents per share. The results surpassed Wall Street expectations. ...